Hormonal Regulation, The Menstrual Cycle, and Embryonic Differentiation in Human Embryology

Interaction of FSH and LH via Negative Feedback

  • Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) function in a coordinated manner to regulate the reproductive system.
  • The interaction of these hormones is heavily governed by a negative feedback loop involving estrogen and progesterone.
  • Negative Feedback Mechanism: If levels of estrogen and progesterone are elevated, the pituitary gland is inhibited, leading to a decrease in the production and release of FSH and LH.
  • This mechanism ensures that as long as the corpus luteum is maintained (secreting high levels of progesterone), no additional eggs are released from the ovaries.
  • Application in Pregnancy:     - During pregnancy, progesterone remains high to maintain the uterine lining, which serves as the nutrient source for the developing fetus.     - Theoretically, a woman cannot get pregnant while already pregnant because high progesterone prevents the release of further eggs.     - In all of documented human history, there have only been approximately 55 cases where a woman released an egg and became pregnant while already pregnant (superfetation).

The Uterine and Ovarian Cycles: Timing and Phases

  • Cycle Documentation:     - Day 1: This is defined as the first day of bleeding/menstruation, not the last.     - Cycle Length: A typical cycle is approximately 2828 days long, though this varies between individuals.     - Ovulation: Occurs halfway through the cycle, typically on Day 14.
  • Pregnancy Risk and Timing:     - Submitting to unprotected intercourse on Day 14 constitutes the highest risk for pregnancy because the egg has been released and is available for fertilization.     - Conversely, the least likely time to conceive is during the menstrual period when the uterine lining is being shed and the egg is exiting the body.
  • Proliferative Phase:     - The word "proliferative" contains the prefix "pro-life."     - During this phase, the body builds a new uterine lining in preparation to support a potential developing embryo.
  • Mittelschmerz:     - This term refers to the sharp pelvic pain some women experience during ovulation.     - By tracking the cycle and counting approximately 1414 to 1515 days from the start of the bleeding cycle, women can identify this pain as the physical sensation of an egg being released.
  • Cycle Integration: The ovarian cycle (changes in the follicle) and the uterine cycle (changes in the lining) occur simultaneously over the course of one month. A spike in LH triggers ovulation, followed by the formation of the corpus luteum, which secretes progesterone to thicken and maintain the lining. If no pregnancy occurs, the corpus luteum breaks down, progesterone levels drop, and the lining is shed, restarting the process.

Hormonal Birth Control: Mechanisms and Medical Applications

  • Mechanism of Action: Birth control pills typically contain a combination of estrogen and progesterone.     - By maintaining high levels of these hormones exogenously (from the outside), the body’s endogenous (internal) production of FSH and LH is suppressed via negative feedback.     - Because FSH and LH are depressed, no egg is released, thereby preventing pregnancy.
  • Structure of the Pill Packet:     - A standard packet often contains one row of "candy" or sugar pills (placebos) for the final week of the cycle.     - These are used to maintain the habit of taking a pill every single day at the same time (e.g., breakfast, lunch, or dinner).     - During the placebo week, the lack of exogenous progesterone causes a "withdrawal bleed," allowing the user to experience a regular monthly cycle.
  • Medical Uses Beyond Contraception:     - The pill is frequently prescribed to regulate severe menstrual flow and manage menstrual cramps.     - It can make periods more predictable and lighter by regulating hormonal fluctuations.
  • Exogenous vs. Endogenous Effects:     - Introducing hormones exogenously signal the body to stop its own production. For example, exogenous testosterone can cause testicles to shrink (atrophy).     - Long-term use of the pill (e.g., 2020 years) can lead to an unpredictable cycle once the user stops taking it, as the body must restart its endogenous cycle, which may take several months to stabilize.
  • Stress Impact: High levels of stress increase testosterone levels, which can counteract estrogen and disrupt the uterine cycle.

Progesterone: Physiological Benefits and Withdrawal Syndromes

  • The "Progesterone Glow": This hormone is responsible for the glowing appearance often attributed to pregnant women.     - Physical benefits of high progesterone include clearing up acne, making hair soft and shiny, and making nails flexible.     - Progesterone also acts as a mood elevator.
  • Premenstrual Syndrome (PMS):     - PMS is caused by the sudden drop in progesterone just before menstruation begins.     - As progesterone levels fall, the "mood-elevating" effect is lost, leading to irritability, skin breakouts, frizzy hair, and brittle nails.
  • Postpartum Depression:     - Postpartum is a significant chemical and emotional shift occurring after childbirth.     - Chemically, a woman drops from 4040 weeks of high progesterone to nearly zero in a single day.     - Social/Emotional factors: The shift in attention from the mother to the baby, extreme sleep deprivation, and the physical demands of feeding and care contribute to this state.

Psychological and Behavioral Effects of Hormonal Alteration

  • The PNAS Study on Attractiveness:     - A study of 118118 women published in the Proceedings of the National Academy of Sciences found that hormonal birth control might influence mate selection.     - Women who were on the pill when they met their husbands and then stopped taking it reported changes in relationship satisfaction.     - Those with objectively attractive husbands remained satisfied, while those with less attractive husbands became less satisfied after the hormonal shift.
  • Major Histocompatibility Complex (MHC) and Scent:     - Mice naturally seek mates with different MHC genes to strengthen the immune systems of their offspring.     - A Swiss study found that female mice on birth control reversed this preference, choosing mates with similar MHC genes.     - Human T-Shirt Study: In a study by the Proceedings of the Royal Society of B, women were asked to smell t-shirts worn by men for two nights. Women on the pill rated the scent of men with similar MHC genetic material as more pleasant, which is the opposite of a natural, non-hormonal preference.     - This suggests that being on the pill might lead women to choose partners who are more genetically similar to them (often compared to choosing someone like their father).

Embryology: Sex Differentiation and the SRY Gene

  • Early Development: Until approximately the 1212th week after fertilization, all human embryos look essentially the same.     - Early structures include a tail, a singular opening for solid and liquid waste, and a belly button (which is initially part of the urinary bladder).     - Gonads begin high up in the abdomen; eventually, the kidneys move up while the gonads move down.
  • The SRY Gene: Sex is NOT determined solely by XX and YY chromosomes, but specifically by the SRY gene (Sex-determining Region Y).     - The SRY gene is usually found on the YY chromosome but can occasionally be on the XX.
  • Male Differentiation: Under the influence of the SRY gene and testosterone (starting around the 1111th week):     - The structures that would become fallopian tubes break down.     - Gonads differentiate into testes, and the vas deferens forms.     - The testes are pulled down into the scrotum.     - The tubercle elongates to become the penis, and the urogenital opening closes.
  • Female Differentiation: In the absence of the SRY gene:     - The fallopian tubes persist and develop.     - The boy structures (vas deferens) break down.     - Gonads differentiate into ovaries.     - The tubercle shrinks to become the clitoris, and the yellow folds become the labia majora.
  • Homologies: Most male and female reproductive structures are homologous (developed from the same embryonic tissue).
  • Developmental Anomalies: In some males, the urogenital opening fails to close correctly (hypospadias). This is not an incision but a failure of the opening to suture itself during development, which may require surgery later for hygiene and function.

Clinical Consequences: Teratogens

  • Thalidomide Case Study: A drug once used to treat morning sickness in pregnant women.     - If taken during the 99th week of pregnancy, it disrupts the elongation of the humerus, resulting in hands attached directly to the shoulders (no arms).     - If taken during the 1010th week, it disrupts the elongation of the femur, resulting in feet attached to the hips (no legs).     - These conditions were historically referred to by the derogatory term "Humpty Dumpty" babies.
  • Clinical Warning: Women must be extremely cautious about any substances introduced into their bodies during the critical windows of embryonic development to avoid permanent structural anomalies.